VIEWS: 134 PAGES: 3 CATEGORY: Medicine POSTED ON: 6/3/2010
A global leader in serving libraries of all types, ProQuest LLC (“ProQuest”) supports the breadth of the information community with innovative discovery solutions that power the business of books and the best in research experience. More than a content provider or aggregator, ProQuest is an information partner, creating indispensable research solutions that connect people and information. Through innovative, user-centered discovery technology, ProQuest offers billions of pages of global content that includes historical newspapers, dissertations, and uniquely relevant resources for researchers of any age and sophistication—including content not likely to be digitized by others.
057_MPR_1208.qxp 11/21/2008 1:08 PM Page 1 ENTRY FORMAT Brand name: The main name under which contains a warning that the product should the product and all other dosage forms in not be used in a certain condition, it is shown the monograph are marketed. within this publication as either a contrain- Company: The name of the company to con- dication or as a precaution with a qualifying tact for more medical information. statement such as “not for use in” or “not recommended” depending on how the Legal category: Federal schedule. The laws official labeling is worded. Although not governing the prescribing/dispensing of explicitly stated, hypersensitivity to the products vary from state to state. drug, to others in its class, to related drugs, Pharmacologic class: The chemical/thera- or to any of its excipients, is assumed to be a peutic class of the drug is listed in italics. contraindication in all entries. Interacting Generic name: The active ingredients and contraindicated drugs not marketed in the strengths are listed under the name of each United States are not included. dosage form. If the product contains Precautions: Conditions in which special tartrazine, alcohol, flavors, or is alcohol-, attention is required for patients. Also listed sugar-, or dye-free, it is noted. Abbrevia- are recommended tests that should be tions are used to describe the dosage form performed during therapy, e.g., “Monitor and its formulation, e.g., tabs, caps, “e-c” = renal function”; special side effects that may enteric coated, “sust rel” = sustained- necessitate the discontinuation of therapy; release, “ext rel” = extended-release. and warnings to patients, e.g., “If serious Also: Other formulations of the product diarrhea occurs, discontinue therapy.” If a appear as “ALSO” within the same entry. decision must be made whether to Generally, only those forms used by office- discontinue nursing or discontinue the drug, based practitioners are listed. or if a drug should generally not be used in pregnancy, the phrase “not recommended” Indications: Only the approved indications is used. are listed. The wording may be condensed, e.g., “Edema” and not “Edema due to car- Interactions: Drug, some food and labora- diac failure, hepatic cirrhosis, etc.” When a tory test interactions appear here, such as product has more than one indication, it may potentiation and/or antagonism of the ref- appear in other therapeutic sections. Only erence drug’s effects and any other clinical- the indications relevant to the therapeutic ly important potential interactions. When section in which the entry appears are shown. an interaction is suspected, all relevant drugs should be checked since reciprocal Dose: Adults: Standard doses with the ac- effects are not necessarily listed. Interacting knowledgement that doses should be indi- drugs not marketed in the United States are vidualized according to pa
Pages to are hidden for
"ENTRY FORMAT"Please download to view full document